Clene to Present at Upcoming Investor Conferences

Rhea-AI Summary

Clene Inc. (NASDAQ: CLNN) will participate in several upcoming investor conferences, showcasing its commitment to revolutionizing the treatment of neurodegenerative diseases. The company will present at the H.C. Wainwright Global Investment Conference on May 25, 2022, at 2 p.m. ET, followed by participation in the Benchmark Healthcare House Call Virtual 1x1 Conference on June 2, 2022, and the JMP Securities Life Sciences Conference on June 15, 2022, also at 2 p.m. ET. Clene focuses on addressing energetic failure, a key factor in many neurological conditions.

SALT LAKE CITY, May 16, 2022 (GLOBE NEWSWIRE) -- Clene Inc. (NASDAQ: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., a clinical-stage biopharmaceutical company focused on revolutionizing the treatment of neurodegenerative disease, today announced that it will participate in the following investor conferences:

• H.C. Wainwright Global Investment Conference, May 24-26, 2022
  Presentation Time: May 25, 2022, at 2 p.m. ET

• Benchmark Healthcare House Call Virtual 1x1 Conference, June 2, 2022
  
  
• JMP Securities Life Sciences Conference, June 15-16, 2022
  Presentation Time: June 15, 2022, at 2 p.m. ET

About Clene
Clene is a clinical-stage biopharmaceutical company focused on revolutionizing the treatment of neurodegenerative disease by targeting energetic failure, an underlying cause of many neurological diseases. The company is based in Salt Lake City, Utah, with R&D and manufacturing operations in Maryland. For more information, please visit www.clene.com or follow us on Twitter, LinkedIn and Facebook.

Media Contact
Erica Fiorini, Ph.D., or David Schull
Russo Partners, LLC
Erica.fiorini@russopartnersllc.com
David.schull@russopartnersllc.com
+1-212-845-4253

Investor Contact
John Woolford
Managing Director, Westwicke
clene@westwicke.com
+1-443-213-0506

Source: Clene Inc.

FAQ

When will Clene Inc. present at the H.C. Wainwright Global Investment Conference?

Clene Inc. will present on May 25, 2022, at 2 p.m. ET during the H.C. Wainwright Global Investment Conference.

What are the dates for the Benchmark Healthcare House Call Virtual 1x1 Conference?

The Benchmark Healthcare House Call Virtual 1x1 Conference is scheduled for June 2, 2022.

When is Clene Inc. participating in the JMP Securities Life Sciences Conference?

Clene Inc. will participate in the JMP Securities Life Sciences Conference on June 15, 2022, with a presentation at 2 p.m. ET.

What is Clene Inc.'s focus in biopharmaceuticals?

Clene Inc. is focused on revolutionizing the treatment of neurodegenerative diseases by targeting energetic failure.

Where is Clene Inc. based?

Clene Inc. is based in Salt Lake City, Utah, with R&D and manufacturing operations in Maryland.